share_log

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $45

Benzinga ·  Mar 29, 2023 06:13

HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience (NASDAQ:AADI) with a Buy and lowers the price target from $48 to $45.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment